Clinical and Molecular Hepatology (Clin Mol Hepatol), is an international, peer-reviewed, open- access journal published quarterly in English. Clin Mol Hepatol aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, Clin Mol Hepatol gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.
临床和分子肝病学（Clin Mol Hepatology）是一种国际性、同行评审、开放获取期刊，每季度以英语出版。《临床与分子肝病》旨在分享肝胆疾病的先进和最新知识、趋势和理解，为临床医生、转化研究人员和基础科学家提供一个广泛开放的学术论坛，并通过多学科方法改善公共卫生，特别是在B病毒感染和肝细胞癌高发的资源有限的亚太地区。此外，《临床分子肝病学》还重点研究东亚、北亚、东南亚、中亚、南亚、西南亚、太平洋、非洲、中欧、东欧、中美洲和南美洲的肝胆疾病的流行病学研究。
Recent research trends and updates on nonalcoholic fatty liver disease
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0037
Radiomics and radiogenomics of primary liver cancers
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.1007
Unmet need in chronic hepatitis B management
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0106
Application of transient elastography in nonalcoholic fatty liver disease
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0001n
Pathologic differential diagnosis of metastatic carcinoma in the liver
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0067
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.1001
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0040
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0010
Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0108
Ultraselective conventional transarterial chemoembolization: When and how?
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0016
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0061
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0004
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0029
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0065
Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0039
Extrahepatic manifestations of hepatitis E virus: An overview
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0082
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0107
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0022
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0015
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0073
Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0039
Drug induced liver injury: East versus West – a systematic review and meta-analysis
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.1003
Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0037
KASL clinical practice guidelines for management of chronic hepatitis B
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.1002
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0006
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.1014
Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0086
Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0084
The management of polycystic liver disease by tolvaptan
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0026
Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0074
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0031
Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0023
Advances in ultrasound diagnosis in chronic liver diseases
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.1013
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.1011
The fibrogenic process and the unleashing of acute-on-chronic liver failure
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0011
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0103
Evaluation of bioenergetic and mitochondrial function in liver transplantation
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0087
Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0083
Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0005
Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0097
Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.1010
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0101
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0078
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0034
Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0030
Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0051
Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0111
Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0084
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2018.0070
Multimodal sequential treatment for occluded TIPS: Case report and review of literature
来源期刊：Clinical and Molecular HepatologyDOI：10.3350/cmh.2019.0056
